Dr. Eyad I. Abu-Isa, MD

  • Novi, MI
  • Radiation oncologist
NPI1396861936PAC ID3476724907
Medicare services, 2024
1,962
Medicare patients, 2024
108
Part D claims, 2024
118
Publications
13
Hospital affiliations
3
Practice address
47601 Grand River Ave, Novi, MI 48374
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

St John Hospital and Medical Center - Assarian Cancer Center - HOPD

Acute Care Hospital outpatient department · Novi, Michigan

See all 15 affiliations

Find Dr. Abu-Isa's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Eyad I. Abu-Isa is a radiation oncologist in Novi, Michigan

Dr. Abu-Isa practices at St John Hospital and Medical Center - Assarian Cancer Center - HOPD in Novi, Michigan.

Dr. Abu-Isa's NPI, 1396861936, was assigned on March 22, 2007. Dr. Abu-Isa graduated from University Of Michigan Medical School in 2006. Dr. Abu-Isa holds Michigan license 4301087851.

NPI and contact details
Medicare PAC ID
3476724907
NPI enumeration date
March 22, 2007
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
46
Medical school graduation
2006

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Eyad I. Abu-Isa practices at St John Hospital and Medical Center - Assarian Cancer Center - HOPD in Novi, Michigan

Dr. Abu-Isa's primary practice is St John Hospital and Medical Center - Assarian Cancer Center - HOPD, at 47601 Grand River Ave, Novi, MI 48374.

  • St John Hospital and Medical Center - Assarian Cancer Center - HOPD
    47601 Grand River Ave, Novi, MI 48374

Source: Dmand AI Affiliation Data

Dr. Eyad I. Abu-Isa is affiliated with 8 sites of care and 7 medical groups

Dr. Abu-Isa's primary practice is St John Hospital and Medical Center - Assarian Cancer Center - HOPD in Novi, Michigan. Dr. Abu-Isa is also affiliated with Henry Ford Providence Southfield Hospital. The medical group on file is PMHC Cancer Center. Dmand AI also links Dr. Abu-Isa to 2 more hospitals, 6 medical groups, 3 group practices and clinics and 1 clinical lab, each named with a free account.

See all 15 affiliations for Dr. Abu-Isa

Source: Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Eyad I. Abu-Isa's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abu-Isa practices, 8 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
St John Hospital and Medical Center - Assarian Cancer Center - HOPDAvailable with a free account
+7 more sites and 6 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Abu-Isa practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Eyad I. Abu-Isa is one of 200 radiation oncologists in Michigan

Radiation oncology is Dr. Abu-Isa's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Abu-Isa is board certified in radiation oncology by the American Board of Radiology. Dr. Abu-Isa is licensed in Michigan.

Specialties and state licenses

  • Radiation oncology, MichiganPrimaryLicense 4301087851 · 2011 to 2027 · taxonomy 2085R0001X

Clinical focus

Dmand AI lists bone cancer radiation, breast cancer radiation, cancer radiation-upper GI, head & neck cancer radiation, lung cancer radiation, lymphoma radiation and pancreatic cancer radiation among the conditions Dr. Abu-Isa treats.

Radiation oncologists near Dr. Abu-Isa

Counts of radiation oncologists with a Dmand AI profile, by place and practice. Each opens the list.

200radiation oncologists in Michigan
4radiation oncologists in Novi

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Eyad I. Abu-Isa billed Medicare for 1,962 services in 2024

CMS data shows 1,962 Medicare services from Dr. Abu-Isa across 18 procedure codes in 2024, for 108 Medicare patients. Medicare paid $392,486 for them. Every service was in an office.

Medicare services, 20241,962
Medicare patients108
Paid by Medicare$392,486
Procedure codes18

Dr. Abu-Isa's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Imaging
2023: 1,3242024: 1,2307%
Other services
2023: 7812024: 62220%
Office and hospital visits
2023: 892024: 11024%

Dr. Abu-Isa compared with the Michigan median for radiation oncologists, 2024

  • Dr. Abu-Isa
  • Michigan median
Medicare services
1,962vs 1,14871% above
Medicare patients
108vs 13319% below
Part D claims
47vs 3824% above

Medians across 184 radiation oncologists in Michigan with Dmand AI profiles that report each measure.

Dr. Abu-Isa's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Abu-Isa

Need commercial claims for Dr. Abu-Isa?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Abu-Isa and other radiation oncologists in Michigan.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Eyad I. Abu-Isa treated 108 Medicare patients in 2024, average age 74

CMS counts 108 Medicare patients who saw Dr. Abu-Isa in 2024. The largest group is 65 to 74, with 45 patients. 75% of them have cancer, and 75% have high blood pressure. 21% are also on Medicaid. Their average risk score is 2.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abu-Isa's median patient age at 69, with 68% women.

Medicare patients, 2024108
Average age74
Average risk score2.01
Also on Medicaid21%

Dr. Abu-Isa's Medicare patients by age, 2024

Dr. Abu-Isa's Medicare patients by sex, 2024

  • Women6661%
  • Men4239%

Chronic conditions among Dr. Abu-Isa's Medicare patients, 2024

  1. Cancer75%
  2. High blood pressure75%
  3. High cholesterol70%
  4. Diabetes43%
  5. Arthritis39%
  6. COPD33%
  7. Ischemic heart disease33%
  8. Atrial fibrillation25%

Share of Medicare patients with each condition. A patient can have several.

Dr. Abu-Isa's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 69

Patient panel by sex, all payers

  • Women68%
  • Men32%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Eyad I. Abu-Isa wrote 118 Medicare Part D claims in 2024

In 2024, Dr. Abu-Isa wrote 118 Medicare Part D claims for 52 patients. 91% of them were for generic drugs. CMS names the drug for 47 of them, across 2 drugs with 11 or more claims each, at $1,414 in total drug cost. In 2023, CMS named 24 claims across 2 drugs.

Part D claims, 2024118
Drugs named by CMS2
Total drug cost$1,414
Part D patients52

Dr. Abu-Isa's Part D claims by kind of drug, 2024

  • Generic107 claims91%
  • Brand-name11 claims9%

Dr. Abu-Isa's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Abu-Isa's Part D claims, 2024

  • Opioids15%18 of 118 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 242024: 4796%

Drugs named by CMS: 2 in 2024, 2 in 2023.

See all prescribing by Dr. Abu-Isa

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Eyad I. Abu-Isa offers telehealth to Medicare patients

Dr. Abu-Isa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Abu-Isa as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find radiation oncologists like Dr. Abu-Isa by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Eyad I. Abu-Isa has 13 publications on record

Dmand AI links 13 papers to Dr. Abu-Isa, published from 2012 to 2023. 2021 was the busiest year, with 4. The most frequent topics are Prostatic Neoplasms, Radiotherapy Dosage and Breast Neoplasms. Dr. Abu-Isa has published most often in Int J Radiat Oncol Biol Phys. Dr. Abu-Isa's most frequent co-authors are Michael Matthew Dominello, DO, Daniel Allan Hamstra, MD, PhD and Lori Jo Pierce, MD.

Papers13
Years published2012 to 2023

Dr. Abu-Isa's papers by year, 2012 to 2023

Topics Dr. Abu-Isa writes about most

  • Prostatic Neoplasms
  • Radiotherapy Dosage
  • Breast Neoplasms
  • Brachytherapy
  • Androgen Antagonists
  • Heart
  • Neoplasm Grading
  • Prostate-Specific Antigen

Dr. Abu-Isa's most frequent co-authors

Recent publications by Dr. Abu-Isa

See all 13 publications and co-authors

See who Dr. Abu-Isa researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Abu-Isa works with, so you can find a warm path to the right radiation oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Eyad I. Abu-Isa received $4,745 in industry payments from 2016 to 2025

CMS Open Payments shows 87 general payments to Dr. Abu-Isa from 24 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 66% of the total. AstraZeneca Pharmaceuticals LP paid the most, $3,317.

General payments to Dr. Abu-Isa by program year, 2016 to 2025

General payments to Dr. Abu-Isa by kind, 2016 to 2025

$4.7Kin total
  • Consulting fees$3,15066%
  • Food and beverage$1,59534%

Companies that paid Dr. Abu-Isa the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Abu-Isa

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Eyad I. Abu-Isa graduated from University Of Michigan Medical School

Dr. Abu-Isa graduated from University Of Michigan Medical School in 2006.

  1. Medical schoolUniversity Of Michigan Medical School
  2. Board certified in radiation oncologyAmerican Board of Radiology

Source: Dmand AI Professional Profile Data

Dr. Eyad I. Abu-Isa accepts plans from 19 insurance carriers

Dr. Abu-Isa is in network with 19 carriers, including Aetna, Health Alliance Plan and Priority Health. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.

Plan types Dr. Abu-Isa accepts, by number of carriers

  1. PPO12
  2. HMO11
  3. Medicare10
  4. POS6
  5. EPO5
  6. Medicaid2

Source: Dmand AI Insurance Network Data

Sources for Dr. Eyad I. Abu-Isa's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Eyad I. Abu-Isa

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Eyad I. Abu-Isa's NPI number?

Dr. Eyad I. Abu-Isa's NPI number is 1396861936. It was assigned on March 22, 2007, and it is active in the NPI Registry.

What kind of doctor is Dr. Eyad I. Abu-Isa?

Dr. Eyad I. Abu-Isa is a radiation oncologist in Novi, Michigan. The primary specialty in the NPI Registry is Radiation Oncology Physician (taxonomy code 2085R0001X).

Where does Dr. Eyad I. Abu-Isa practice?

Dr. Abu-Isa practices at 47601 Grand River Ave, Novi, MI 48374. Dr. Abu-Isa's primary practice is St John Hospital and Medical Center - Assarian Cancer Center - HOPD in Novi, Michigan. Dmand AI also links Dr. Abu-Isa to 2 hospitals, 6 medical groups, 3 group practices and clinics and 1 clinical lab.

What is Dr. Eyad I. Abu-Isa's medical license number?

Dr. Abu-Isa holds Michigan license 4301087851.

Which hospitals is Dr. Eyad I. Abu-Isa affiliated with?

Dr. Abu-Isa is affiliated with Henry Ford Providence Southfield Hospital. Dmand AI links Dr. Abu-Isa to 2 more hospitals.

What medical group is Dr. Eyad I. Abu-Isa part of?

Dr. Abu-Isa is linked to PMHC Cancer Center. Dmand AI links Dr. Abu-Isa to 6 more medical groups.

Does Dr. Eyad I. Abu-Isa accept Medicare?

Yes. CMS data shows Dr. Abu-Isa billed Medicare for 1,962 services in 2024, and Dr. Abu-Isa accepts Medicare assignment.

Does Dr. Eyad I. Abu-Isa offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Abu-Isa as offering telehealth services.

How many Medicare patients does Dr. Eyad I. Abu-Isa see?

CMS counts 108 Medicare patients who saw Dr. Abu-Isa in 2024, with an average age of 74.

Is Dr. Eyad I. Abu-Isa board certified?

Yes. Dr. Abu-Isa is board certified in radiation oncology by the American Board of Radiology.

Show 8 more questionsShow fewer questions

What services does Dr. Eyad I. Abu-Isa bill to Medicare?

In 2024, Dr. Abu-Isa's most billed Medicare services were medicare service (G6015), radiation oncology (77014) and radiation oncology (77300).

Where did Dr. Eyad I. Abu-Isa go to medical school?

Dr. Abu-Isa graduated from University Of Michigan Medical School in 2006.

What drugs does Dr. Eyad I. Abu-Isa prescribe most?

In 2024 Medicare Part D data, Dr. Abu-Isa's most prescribed drugs by claims were Lidocaine HCl Viscous and Dexamethasone.

Has Dr. Eyad I. Abu-Isa received payments from drug or device companies?

CMS Open Payments shows $4,745 in general payments to Dr. Abu-Isa from 24 companies from 2016 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.

How long has Dr. Eyad I. Abu-Isa been practicing?

Dr. Abu-Isa graduated from medical school in 2006, 20 years ago.

Does Dr. Eyad I. Abu-Isa do research?

Dmand AI links 13 publications to Dr. Abu-Isa, published from 2012 to 2023.

Who does Dr. Eyad I. Abu-Isa publish with?

Dr. Abu-Isa's most frequent co-authors are Michael Matthew Dominello, DO (4 shared papers), Daniel Allan Hamstra, MD, PhD (4 shared papers) and Lori Jo Pierce, MD (4 shared papers).

What insurance does Dr. Eyad I. Abu-Isa accept?

Dr. Abu-Isa is in network with 19 carriers, including Aetna, Health Alliance Plan and Priority Health. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.

Selling to radiation oncology practices?

See radiation oncologists in Michigan by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)